CUPERTINO, Calif. (AP) _ Cellular Biomedicine Group Inc. (CBMG) on Thursday reported a loss of $6.2 million in its third quarter.
On a per-share basis, the Cupertino, California-based company said it had a loss of 43 cents.
The biotechnology company posted revenue of $106,800 in the period. Its adjusted revenue was $107,000.
Cellular Biomedicine shares have fallen 21 percent since the beginning of the year. The stock has dropped 8 percent in the last 12 months.